Ahmedabad
based Lincoln Pharmaceuticals Ltd. (LPL), announced that it has launched
Caroverine injection under the brand name ‘TINNITIN’ which is India’s first
drug to treat Tinnitus – a disease commonly known as ‘ringing in the ear’.
The company developed Caroverine injection under research and development collaboration with Phafag AG, a Switzerland-based drug manufacturing firm.
Tinnitus is a condition where the inner hair cells get damaged causing continuous depression, anxiety and insomnia in patients.
The company has also received permission from the Drugs Controller General of India (DCGI) for registration of the drug in India.
LPL, will be the sole manufacturers and distributors for the TINNITIN Injection in India.
The company developed Caroverine injection under research and development collaboration with Phafag AG, a Switzerland-based drug manufacturing firm.
Tinnitus is a condition where the inner hair cells get damaged causing continuous depression, anxiety and insomnia in patients.
The company has also received permission from the Drugs Controller General of India (DCGI) for registration of the drug in India.
LPL, will be the sole manufacturers and distributors for the TINNITIN Injection in India.
No comments:
Post a Comment